1161 related articles for article (PubMed ID: 3020684)
1. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
Zanetti A
Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
[TBL] [Abstract][Full Text] [Related]
4. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
6. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
7. [Current status and therapeutic strategy for hepatocellular carcinoma].
Unoura M; Adachi K; Kawai H; Inagaki Y; Kaneko S; Kobayashi K
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):608-14. PubMed ID: 2157367
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
11. [The relation of infection with the hepatitis B-agent to primary hepatic carcinoma (author's transl)].
Blumberg BS; Larouzé B; London WT; Werner B; Hesser JE; Millman I; Saimot G; Payet M
Leber Magen Darm; 1976 Dec; 6(6):309-15. PubMed ID: 190499
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus and the control of hepatocellular carcinoma.
Blumberg BS
IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
Omata M; Ashcavai M; Liew CT; Peters RL
Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
[TBL] [Abstract][Full Text] [Related]
14. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
17. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
18. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
[TBL] [Abstract][Full Text] [Related]
19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
